Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

106
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
106
Statistical Methods for Analyzing Epidemiological Data01:25

Statistical Methods for Analyzing Epidemiological Data

239
Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
239
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

57
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
57
Statistical Software for Data Analysis and Clinical Trials01:12

Statistical Software for Data Analysis and Clinical Trials

354
Statistical software is pivotal in data analysis and clinical trials by providing tools to analyze data, draw conclusions, and make predictions. These software packages range from simple data management applications to complex analytical platforms, supporting various statistical tests, models, and simulation techniques. Their significance lies in their ability to handle vast amounts of data with precision and efficiency, enabling researchers to validate hypotheses, identify trends, and make...
354
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

47
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
47
Parametric Survival Analysis: Weibull and Exponential Methods01:14

Parametric Survival Analysis: Weibull and Exponential Methods

278
Parametric survival analysis models survival data by assuming a specific probability distribution for the time until an event occurs. The Weibull and exponential distributions are two of the most commonly used methods in this context, due to their versatility and relatively straightforward application.
Weibull Distribution
The Weibull distribution is a flexible model used in parametric survival analysis. It can handle both increasing and decreasing hazard rates, depending on its shape parameter...
278

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Heterogeneous domain adaptation survival analysis with partially observed outcomes via dictionary learning and distribution alignment.

Journal of biomedical informatics·2026
Same author

Molecular mechanism leading to human coronary atherosclerosis assessed by proteomic analysis and RNA sequences.

European heart journal·2026
Same author

Mechanical circulatory support as a bridge to cancer therapy in patients with end stage heart failure: a single center experience.

Journal of artificial organs : the official journal of the Japanese Society for Artificial Organs·2026
Same author

Mental Health and Substance Use Disorders in Advanced Heart Failure Patients Undergoing VAD Implantation and Cardiac Transplantation: How Much do We Know?

Current cardiology reviews·2026
Same author

Machine Learning Models for Posttransplant Lymphoproliferative Disorder (PTLD) Risk Prediction in Thoracic Transplantation.

ASAIO journal (American Society for Artificial Internal Organs : 1992)·2026
Same author

Determining Causes of Insulin-Induced Hypoglycemia Using an Electronic-Based Trigger.

American journal of medical quality : the official journal of the American College of Medical Quality·2026

Related Experiment Video

Updated: May 12, 2025

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.0K

Scalable Bayesian Nonparametric Method for Clinical Risk Prediction Using Large-Scale Data From Heterogeneous

Ning Dong, Nandini Nair, Dongping Du

    IEEE Journal of Biomedical and Health Informatics
    |May 7, 2025
    PubMed
    Summary

    This study introduces a scalable Bayesian framework for analyzing large clinical datasets, improving risk prediction accuracy by clustering patients with similar risk profiles. The method efficiently handles patient heterogeneity and complex data patterns.

    More Related Videos

    Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
    07:31

    Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack

    Published on: May 15, 2020

    6.9K
    Establishing a Competing Risk Regression Nomogram Model for Survival Data
    04:57

    Establishing a Competing Risk Regression Nomogram Model for Survival Data

    Published on: October 23, 2020

    10.0K

    Related Experiment Videos

    Last Updated: May 12, 2025

    An R-Based Landscape Validation of a Competing Risk Model
    05:37

    An R-Based Landscape Validation of a Competing Risk Model

    Published on: September 16, 2022

    2.0K
    Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
    07:31

    Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack

    Published on: May 15, 2020

    6.9K
    Establishing a Competing Risk Regression Nomogram Model for Survival Data
    04:57

    Establishing a Competing Risk Regression Nomogram Model for Survival Data

    Published on: October 23, 2020

    10.0K

    Area of Science:

    • Computational statistics
    • Biostatistics
    • Machine learning in healthcare

    Background:

    • Large clinical datasets offer potential for enhanced risk prediction but pose challenges due to patient heterogeneity and data dynamics.
    • Existing risk modeling techniques struggle with complex, overlapping data distributions common in healthcare.
    • Bayesian nonparametric methods like Dirichlet Process Mixture Models (DPMM) are suitable for such data but are computationally intensive for large datasets.

    Purpose of the Study:

    • To develop a scalable framework for constructing Dirichlet Process Mixture Models (DPMMs) from large clinical datasets.
    • To address the computational limitations of DPMMs for big data applications in risk prediction.
    • To improve the accuracy and efficiency of risk prediction models by accounting for patient heterogeneity.

    Main Methods:

    • A scalable framework was developed by dividing large datasets into smaller subsets for parallel DPMM learning.
    • A recentered pseudo-barycenter was used to approximate the full dataset's posterior density.
    • A novel algorithm was designed for consistent clustering from subset posteriors with varying component numbers.

    Main Results:

    • The proposed framework demonstrated improved accuracy in predicting heart failure patient survival post-left ventricular assist device implantation compared to Cox proportional hazards and random survival forests.
    • The method effectively clustered patients into distinct risk subgroups, accounting for overlapping posterior mixtures.
    • Validation through simulation and a clinical case study confirmed the framework's efficacy.

    Conclusions:

    • The developed scalable DPMM framework offers an effective approach for analyzing large, heterogeneous clinical datasets.
    • This method enhances risk prediction accuracy by adaptively clustering patients and modeling overlapping risk profiles.
    • The framework provides a computationally feasible solution for applying advanced Bayesian methods to real-world clinical data challenges.